Immunoisolation: Where regenerative medicine meets solid organ transplantation

Expert Review of Clinical Immunology

Volumn 8, Issue 7, 2012, Pages 685-692

  Pareta, Rajesh ^a   Sanders, Brian ^a   Babbar, Paurush ^a   Soker, Tom ^a   Booth, Christopher ^a   Mcquilling, John ^a   Sivanandane, Sittadjody ^a   Stratta, Robert J ^a   Orlando, Giuseppe ^a   Opara, Emmanuel C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

immunocloaking; immunoisolation; islet encapsulation; regenerative medicine

Indexed keywords

ANTIGEN; NANOFILM;

CELL ENCAPSULATION; ENDOTHELIUM CELL; HUMAN; IMMUNOCLOAKING; IMMUNOISOLATION; IMMUNOLOGICAL TECHNIQUE; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; NONHUMAN; NUTRIENT; OXYGEN TRANSPORT; PANCREAS ISLET CELL; REGENERATIVE MEDICINE; REVIEW; SKIN ALLOGRAFT; VASCULARIZATION;

ANIMALS; CAPSULES; HUMANS; IMMUNOSUPPRESSION; ISLETS OF LANGERHANS TRANSPLANTATION; ORGAN TRANSPLANTATION; REGENERATIVE MEDICINE;

EID: 84867785343     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.12.64     Document Type: Review

References (42)

1. Orlando G, Bendala JD, Shupe T et al. Cell and organ bioengineering technology as applied to gastrointestinal diseases. Gut doi:10.1136/gutjnl-2011- 301111 (2012) (Epub ahead of print).
2. Orlando G. Transplantation as a subfield of regenerative medicine. Interview by Lauren Constable. Expert Rev. Clin. Immunol. 7(2), 137-141 (2011).
3. Orlando G. Immunosuppression-free transplantation xpepagin. Immunol. 8(2), 179-187 (2012).
4. Orlando G, Wood KJ, Soker S, Stratta RJ. How regenerative medicine may contribute to the achievement of an immunosuppression-free state. Transplantation 92(8), e36-e38; author reply e39 (2011).
5. Thomas L. The technology of medicine. N. Engl. J. Med. 285(24), 1366-1368 (1971).
6. Oliver TR. Health care reform as a halfway technology. J. Health Polit. Policy Law 36(3), 603-609 (2011).
7. Thomas L. Lives of a Cell. Viking Press, New York, NY, USA (1974).
8. Rubín A, Aguilera V, Berenguer M. Liver transplantation and hepatitis C. Clin. Res. Hepatol. Gastroenterol. 35(12), 805-812 (2011).
9. Orlando G, Hematti P, Stratta RJ et al. Clinical operational tolerance after renal transplantation: current status and future challenges. Ann. Surg. 252(6), 915-928 (2010).
10. Orlando G, Soker S, Wood K. Operational tolerance after liver transplantation. J. Hepatol. 50(6), 1247-1257 (2009).
11. Opara EC, Mirmalek-Sani SH, Khanna O, Moya ML, Brey EM. Design of a bioartificial pancreas(+). J. Investig. Med. 58(7), 831-837 (2010).
12. Hill RS, Cruise GM, Hager SR et al. Immunoisolation of adult porcine islets for the treatment of diabetes mellitus. The use of photopolymerizable polyethylene glycol in the conformal coating of mass-isolated porcine islets. Ann. NY Acad. Sci. 831, 332-343 (1997). (Pubitemid 28045288)
13. Avgoustiniatos ES, Colton CK. Effect of external oxygen mass transfer resistances on viability of immunoisolated tissue. Ann. NY Acad. Sci. 831, 145-167 (1997). (Pubitemid 28045272)
14. O'Sullivan ES, Vegas A, Anderson DG, Weir GC. Islets transplanted in immunoisolation devices: A review of the progress and the challenges that remain. Endocr. Rev. 32(6), 827-844 (2011).
15. Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 210(4472), 908-910 (1980). (Pubitemid 11169847)
16. Calafiore R, Basta G, Luca G et al. Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. Diabetes Care 29(1), 137-138 (2006). (Pubitemid 44033446)
17. Elliott RB, Escobar L, Tan PL, Muzina M, Zwain S, Buchanan C. Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation. Xenotransplantation 14(2), 157-161 (2007). (Pubitemid 46457454)
18. Soon-Shiong P, Feldman E, Nelson R et al. Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets. Transplantation 54(5), 769-774 (1992).
19. Prokop A. Bioartificial pancreas: materials, devices, function, and limitations. Diabetes Technol. Ther. 3(3), 431-449 (2001).
20. de Groot M, Schuurs TA, van Schilfgaarde R. Causes of limited survival of microencapsulated pancreatic islet grafts. J. Surg. Res. 121(1), 141-150 (2004). (Pubitemid 39094108)
21. Kizilel S, Garfinkel M, Opara E. The bioartificial pancreas: Progress and challenges. Diabetes Technol. Ther. 7(6), 968-985 (2005). (Pubitemid 43134004)
22. Pareta RA, McQuilling JP, Farney A et al. Bioartificial pancreas: evaluation of crucial barriers to clinical application. In: Organ Donation and Transplantation - Public Policy and Clinical Perspectives. Randhawa G (Ed.). INTECH Publishers, Rijeka, Croatia 241-266 (2012).
23. Smidsrød O, Skjåk-Braek G. Alginate as immobilization matrix for cells. Trends Biotechnol. 8(3), 71-78 (1990).
24. Holtan S, Zhang Q, Strand WI, Skjåk-Braek G. Characterization of the hydrolysis mechanism of polyalternating alginate in weak acid and assignment of the resulting MG-oligosaccharides by NMR spectroscopy and ESI-mass spectrometry. Biomacromolecules 7(7), 2108-2121 (2006). (Pubitemid 44103350)
25. Maki T, Lodge JP, Carretta M et al. Treatment of severe diabetes mellitus for more than one year using a vascularized hybrid artificial pancreas. Transplantation 55(4), 713-7; discussion 717 (1993).
26. Zekorn T, Horcher A, Siebers U, Federlin K, Bretzel RG. Islet transplantation in immunoseparating membranes for treatment of insulin-dependent diabetes mellitus. Exp. Clin. Endocrinol. Diabetes 103(Suppl. 2), 136-139 (1995). (Pubitemid 26066768)
27. de Vos P, Hamel AF, Tatarkiewicz K. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 45(2), 159-173 (2002). (Pubitemid 34208378)
28. Zielinski BA, Aebischer P. Chitosan as a matrix for mammalian cell encapsulation. Biomaterials 15(13), 1049-1056 (1994). (Pubitemid 24345931)
29. Iwata H, Amemiya H, Matsuda T, Takano H, Hayashi R, Akutsu T. Evaluation of microencapsulated islets in agarose gel as bioartificial pancreas by studies of hormone secretion in culture and by xenotransplantation. Diabetes 38(Suppl. 1), 224-225 (1989). (Pubitemid 19029286)
30. Risbud MV, Bhonde RR. Suitability of cellulose molecular dialysis membrane for bioartificial pancreas: in vitro biocompatibility studies. J. Biomed. Mater. Res. 54(3), 436-444 (2001). (Pubitemid 32016711)
31. Dawson RM, Broughton RL, Stevenson WT, Sefton MV. Microencapsulation of CHO cells in a hydroxyethyl methacrylate-methyl methacrylate copolymer. Biomaterials 8(5), 360-366 (1987).
32. Kessler L, Pinget M, Aprahamian M, Dejardin P, Damgé C. In vitro and in vivo studies of the properties of an artificial membrane for pancreatic islet encapsulation. Horm. Metab. Res. 23(7), 312-317 (1991).
33. Cruise GM, Hegre OD, Lamberti FV et al. In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes. Cell Transplant. 8(3), 293-306 (1999). (Pubitemid 29350225)
34. Donati I, Holtan S, Mørch YA, Borgogna M, Dentini M, Skjåk-Braek G. New hypothesis on the role of alternating sequences in calcium-alginate gels. Biomacromolecules 6(2), 1031-1040 (2005). (Pubitemid 40467852)
35. Mørch YA, Qi M, Gundersen PO et al. Binding and leakage of barium in alginate microbeads. J. Biomed. Mater. Res. A 100(11), 2939-2947 (2012).
36. Soon-Shiong P, Heintz RE, Merideth N et al. Insulin independence in a Type 1 diabetic patient after encapsulated islet transplantation. Lancet 343(8903), 950-951 (1994). (Pubitemid 24117231)
37. Chaikof EL. Engineering and material considerations in islet cell transplantation. Annu. Rev. Biomed. Eng. 1, 103-127 (1999). (Pubitemid 129740007)
38. Wolters GH, Fritschy WM, Gerrits D, van Schilfgaarde R. A versatile alginate droplet generator applicable for microencapsulation of pancreatic islets. J. Appl. Biomater. 3(4), 281-286 (1991).
39. Hallé JP, Leblond FA, Pariseau JF, Jutras P, Brabant MJ, Lepage Y. Studies on small (<300 microns) microcapsules: II-Parameters governing the production of alginate beads by high voltage electrostatic pulses. Cell Transplant. 3(5), 365-372 (1994).
40. Hsu BR, Chen HC, Fu SH, Huang YY, Huang HS. The use of field effects to generate calcium alginate microspheres and its application in cell transplantation. J. Formos. Med. Assoc. 93(3), 240-245 (1994).
41. Dawson RM, Broughton RL, Stevenson WT et al. Microencapsulation of CHO cells in a hydroxyethyl methacrylatemethyl methacrylate copolymer. Biomaterials 8, 360-366 (1987).
42. Desmangles AI, Jordan O, Marquis-Weible F. Interfacial photopolymerization of β-cell clusters: Approaches to reduce coating thickness using ionic and lipophilic dyes. Biotechnol. Bioeng. 72(6), 634-641 (2001).